Friday, December 23, 2011
Meritage Pharma Gets $20M In Deal With ViroPharma
San Diego-based Metritage Pharma, which is developing drugs for treating chronic inflammatory diseases of the esophagus, is gaining up to $20M from ViroPharma, which is buying an exclusive option to acquire Meritage. ViroPharma said it paid an initial $7.5M, and up to an additional $12.5M for the development and exclusive right to purchase the company, upon completion of a series of clinical and regulatory deliverables. ViroPharma said it will have an option to acquire Meritage for $69.9M.

posted on Friday, December 23, 2011(Full story)

SkinIt Names VP
San Diego-based SkinIt, the provider of personalized electronic "skins", said Thursday that it has named Frederik Torstensson as Vice President of Sales and Business Development. Torstensson was prevoiusly at Comarco Wireless, and also served at Kyocera Wireless, OZ Communications, and Ericsson North America.

posted on Friday, December 23, 2011(Full story)

Qualcomm Gets Approval On Spectrum Sale
San Diego-based Qualcomm

posted on Friday, December 23, 2011(Full story)

Viewing Technology Companies Through a New Lens - Los Angeles
Viewing Technology Companies Through a New Lens: The 2012 Outlook.

January 17, 2012 - Skirball Cultural Center

Please join J.H. Cohn's Technology Industry Practice and the law firm of
Stubbs Alderton & Markiles for a panel discussion covering:

- An update on trends and opportunities
- Positioning for liquidity events and growth financings

The market for liquidity events is flourishing as the IPO market improves, private equity flows to growth opportunities, and strategic buyers find the fortitude to tap cash reserves. This forum provides a great opportunity to network and share ideas with other industry leaders. Panelists include: Jay Beaghan, Managing Director of Investment Banking in Imperial Capital; William Quigley is Managing Director of Clearstone Venture Partners; Louis A. Wharton is a Partner at Stubbs, Alderton & Markiles; Steven J. Banks, CPA, is a Partner with J.H. Cohn.

Register today!

Sponsored By


Recent Interviews

Browse Issues